AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 38 filers reported holding AQUINOX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $397,000 | -75.7% | 147,029 | -80.5% | 0.01% | -75.0% |
| Q4 2018 | $1,633,000 | +16.1% | 755,774 | +57.4% | 0.05% | +45.5% |
| Q3 2018 | $1,407,000 | +83.9% | 480,108 | +66.3% | 0.03% | +120.0% |
| Q2 2018 | $765,000 | +179.2% | 288,618 | +1310.2% | 0.02% | +275.0% |
| Q3 2016 | $274,000 | -31.3% | 20,467 | -27.9% | 0.00% | -33.3% |
| Q3 2015 | $399,000 | – | 28,374 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
| RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
| Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
| EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
| Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
| Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
| Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
| Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
| JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
| Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |